skip to main content
Show Results with:

A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity

Evidence - Based Complementary and Alternative Medicine, 2016, Vol.2016 [Peer Reviewed Journal]

Full text available

  • Title:
    A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity
  • Author: Ji, Yosep ; Na-Ri, Kim ; Do-Young, Kim ; Kyong-Tai, Kim ; Ji, Yosep ; Na-Ri, Kim ; Do-Young, Kim ; Kyong-Tai, Kim
  • Found In: Evidence - Based Complementary and Alternative Medicine, 2016, Vol.2016 [Peer Reviewed Journal]
  • Subjects: Obesity ; Insulin Resistance ; Rodents ; Sterols ; Life Sciences ; Lipids ; Diet ; Biosynthesis ; Enzymes ; Biomedical Materials ; Cholesterol ; Laboratories ; Insulin ; Gene Expression ; Metabolic Disorders ; Homeostasis ; Adipocytes ; Transcription Factors
  • Language: English
  • Description: This study investigated the antiobesity effect of an extract of the Fomitopsis pinicola Jeseng-containing formulation (FAVA), which is a combination of four natural components: Fomitopsis pinicola Jeseng; Acanthopanax senticosus; Viscum album coloratum; and Allium tuberosum. High-fat diet- (HFD-) fed male C57BL/6J mice were treated with FAVA (200 mg/kg/day) for 12 weeks to monitor the antiobesity effect and amelioration of nonalcoholic fatty liver diseases (NAFLD). Body and white adipose tissue (WAT) weights were reduced in FAVA-treated mice, and a histological examination showed an amelioration of fatty liver in FAVA-treated mice without decreasing food consumption. Additionally, FAVA reduced serum lipid profiles, leptin, and insulin levels compared with the HFD control group. The FAVA extract suppressed lipogenic mRNA expression levels from WAT concomitantly with the cholesterol biosynthesis level in the liver. These results demonstrate the inhibitory effects of FAVA on obesity and NAFLD in the diet-induced obese (DIO) mouse model. Therefore, FAVA may be an effective therapeutic candidate for treating obesity and fatty liver caused by a high-fat diet.
  • Identifier: ISSN: 1741427X ; E-ISSN: 17414288 ; DOI: 10.1155/2016/7312472

Searching Remote Databases, Please Wait